20110608|t|The thiazolidinedione pioglitazone increases cholesterol biosynthetic gene expression in primary cortical neurons by a PPARgamma-independent mechanism.
20110608|a|In a recent clinical study, the thiazolidinedione (TZD) pioglitazone (Actos was reported to preserve cognitive function in patients with mild to moderate Alzheimer's disease and type II diabetes mellitus. TZDs are agonists of the nuclear hormone receptor peroxisome proliferator-activated receptor-gamma (PPARgamma), are peripheral insulin sensitizers, and have recently been reported to increase mitochondrial biogenesis in the central nervous system and dendritic spine density. We report a transcriptional profile of the TZD pioglitazone and the non-TZD PPARgamma agonist GW347845 in primary cortical culture. We observed that pioglitazone, but not GW347845, increased cholesterol biosynthetic and lipogenic gene expression after 6 h, and the expression of the cholesterol efflux transporters Abca1 and Abcg1 after 24 h. Co-treatment of pioglitazone with the PPARgamma antagonist GW9662 did not significantly reduce these effects, suggesting a PPARgamma-independent mechanism. These findings suggest a novel effect of TZDs in neurons that may be of relevance as a novel approach against Alzheimer's disease.
20110608	4	21	thiazolidinedione	Chemical	MESH:C089946
20110608	22	34	pioglitazone	Chemical	MESH:D000077205
20110608	45	56	cholesterol	Chemical	MESH:D002784
20110608	119	128	PPARgamma	Gene	5468
20110608	184	201	thiazolidinedione	Chemical	MESH:C089946
20110608	203	206	TZD	Chemical	MESH:C089946
20110608	208	220	pioglitazone	Chemical	MESH:D000077205
20110608	222	227	Actos	Chemical	MESH:D000077205
20110608	275	283	patients	Species	9606
20110608	306	325	Alzheimer's disease	Disease	MESH:D000544
20110608	330	355	type II diabetes mellitus	Disease	MESH:D003924
20110608	357	361	TZDs	Chemical	-
20110608	407	455	peroxisome proliferator-activated receptor-gamma	Gene	5468
20110608	457	466	PPARgamma	Gene	5468
20110608	484	491	insulin	Gene	3630
20110608	676	679	TZD	Chemical	MESH:C089946
20110608	680	692	pioglitazone	Chemical	MESH:D000077205
20110608	705	708	TZD	Chemical	MESH:C089946
20110608	709	718	PPARgamma	Gene	5468
20110608	727	735	GW347845	Chemical	MESH:C401311
20110608	782	794	pioglitazone	Chemical	MESH:D000077205
20110608	804	812	GW347845	Chemical	MESH:C401311
20110608	824	835	cholesterol	Chemical	MESH:D002784
20110608	916	927	cholesterol	Chemical	MESH:D002784
20110608	948	953	Abca1	Gene	19
20110608	958	963	Abcg1	Gene	9619
20110608	992	1004	pioglitazone	Chemical	MESH:D000077205
20110608	1014	1023	PPARgamma	Gene	5468
20110608	1035	1041	GW9662	Chemical	MESH:C457499
20110608	1099	1108	PPARgamma	Gene	5468
20110608	1173	1177	TZDs	Chemical	-
20110608	1242	1261	Alzheimer's disease	Disease	MESH:D000544
20110608	Negative_Correlation	MESH:C089946	MESH:D003924
20110608	Association	MESH:D002784	9619
20110608	Negative_Correlation	MESH:D000077205	MESH:D000544
20110608	Negative_Correlation	MESH:D000077205	MESH:D003924
20110608	Positive_Correlation	MESH:D000077205	MESH:D002784
20110608	Negative_Correlation	MESH:C457499	MESH:D000077205
20110608	Association	MESH:D002784	19
20110608	Positive_Correlation	MESH:C401311	5468
20110608	Positive_Correlation	MESH:D000077205	9619
20110608	Negative_Correlation	MESH:C089946	MESH:D000544
20110608	Positive_Correlation	MESH:D000077205	19
20110608	Negative_Correlation	MESH:C457499	5468

